Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Taylor Thompson

Showing results (251-260 of 308) with videos related to

Pageof 31
Sort By:
JAMA|May 19, 2024
Acetaminophen for Prevention and Treatment of Organ Dysfunction in Critically Ill Patients With Sepsis: The ASTER Randomized Clinical TrialLorraine B Ware, D Clark Files, Alpha Fowler, et al.
American Journal of Respiratory and Critical Care Medicine|October 19, 2016
Noninvasive Ventilation of Patients with Acute Respiratory Distress Syndrome. Insights from the LUNG SAFE StudyGiacomo Bellani, John G Laffey, Tài Pham, et al.
Journal of Critical Care|April 27, 2021
Recall of clinical trial participation and attrition rates in survivors of acute respiratory distress syndromeErin F Carlton, Erin Ice, Ryan P Barbaro, et al.
The New England Journal of Medicine|December 12, 2019
Early High-Dose Vitamin D<sub>3</sub> for Critically Ill, Vitamin D-Deficient Patients, Adit A Ginde, Roy G Brower, et al.
American Journal of Respiratory and Critical Care Medicine|May 17, 2012
An official multi-society statement: the role of clinical research results in the practice of critical care medicineMark R Tonelli, J Randall Curtis, Kalpalatha K Guntupalli, et al.
Annals of Intensive Care|January 17, 2015
Design and implementation of the START (STem cells for ARDS Treatment) trial, a phase 1/2 trial of human mesenchymal stem/stromal cells for the treatment of moderate-severe acute respiratory distress syndromeKathleen D Liu, Jennifer G Wilson, Hanjing Zhuo, et al.
The New England Journal of Medicine|May 22, 2019
Early Neuromuscular Blockade in the Acute Respiratory Distress Syndrome, Marc Moss, David T Huang, et al.
JAMA Network Open|February 14, 2023
Assessment of Symptom, Disability, and Financial Trajectories in Patients Hospitalized for COVID-19 at 6 MonthsAndrew J Admon, Theodore J Iwashyna, Lee A Kamphuis, et al.
Intensive Care Medicine|November 16, 2017
Correction to: Potentially modifiable factors contributing to outcome from acute respiratory distress syndrome: the LUNG SAFE studyJohn G Laffey, Giacomo Bellani, Tài Pham, et al.
The Lancet. Respiratory Medicine|November 21, 2018
Treatment with allogeneic mesenchymal stromal cells for moderate to severe acute respiratory distress syndrome (START study): a randomised phase 2a safety trialMichael A Matthay, Carolyn S Calfee, Hanjing Zhuo, et al.
Pageof 31

Showing results (251-260 of 308) with videos related to

Sort By:
Pageof 31
JAMA|May 19, 2024
Acetaminophen for Prevention and Treatment of Organ Dysfunction in Critically Ill Patients With Sepsis: The ASTER Randomized Clinical TrialLorraine B Ware, D Clark Files, Alpha Fowler, et al.
American Journal of Respiratory and Critical Care Medicine|October 19, 2016
Noninvasive Ventilation of Patients with Acute Respiratory Distress Syndrome. Insights from the LUNG SAFE StudyGiacomo Bellani, John G Laffey, Tài Pham, et al.
Journal of Critical Care|April 27, 2021
Recall of clinical trial participation and attrition rates in survivors of acute respiratory distress syndromeErin F Carlton, Erin Ice, Ryan P Barbaro, et al.
The New England Journal of Medicine|December 12, 2019
Early High-Dose Vitamin D<sub>3</sub> for Critically Ill, Vitamin D-Deficient Patients, Adit A Ginde, Roy G Brower, et al.
American Journal of Respiratory and Critical Care Medicine|May 17, 2012
An official multi-society statement: the role of clinical research results in the practice of critical care medicineMark R Tonelli, J Randall Curtis, Kalpalatha K Guntupalli, et al.
Annals of Intensive Care|January 17, 2015
Design and implementation of the START (STem cells for ARDS Treatment) trial, a phase 1/2 trial of human mesenchymal stem/stromal cells for the treatment of moderate-severe acute respiratory distress syndromeKathleen D Liu, Jennifer G Wilson, Hanjing Zhuo, et al.
The New England Journal of Medicine|May 22, 2019
Early Neuromuscular Blockade in the Acute Respiratory Distress Syndrome, Marc Moss, David T Huang, et al.
JAMA Network Open|February 14, 2023
Assessment of Symptom, Disability, and Financial Trajectories in Patients Hospitalized for COVID-19 at 6 MonthsAndrew J Admon, Theodore J Iwashyna, Lee A Kamphuis, et al.
Intensive Care Medicine|November 16, 2017
Correction to: Potentially modifiable factors contributing to outcome from acute respiratory distress syndrome: the LUNG SAFE studyJohn G Laffey, Giacomo Bellani, Tài Pham, et al.
The Lancet. Respiratory Medicine|November 21, 2018
Treatment with allogeneic mesenchymal stromal cells for moderate to severe acute respiratory distress syndrome (START study): a randomised phase 2a safety trialMichael A Matthay, Carolyn S Calfee, Hanjing Zhuo, et al.
Pageof 31